
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
Transposable elements (TEs), also known as jumping genes, are DNA sequences capable of moving from one genomic location to another. First discovered by Barbara McClintock, TEs are now recognized as ubiquitous components of genomes across both prokaryotes and eukaryotes. In many organisms, they constitute a substantial proportion of the genome—for example, approximately 50% of the human genome and up to 90% of the maize genome.

Class I transposons, also known as retrotransposons, transpose via a "copy-and-paste Ctrl C+V" mechanism (Figure 1). They first replicate themselves as RNA transcripts, which are then reverse-transcribed back into DNA by an enzyme called reverse transcriptase, ultimately inserting into a new target site. This is similar to the replication mechanism of retroviruses such as HIV.

Class II transposons are also called DNA transposons because they do not require RNA mediation for their movement. Most class II transposons employ a non-replicative "cut and paste Ctrl X+V" transposition mechanism: they excise themselves from one location and then insert themselves at another (Figure 2). Class II transposons have long terminal repeats (LTRs) at both ends.

Although there are many different types of transposons, DNA transposons are most commonly used for genome manipulation in the laboratory. When using transposons in the laboratory, the transposase gene is provided in trans to insert the target gene between the transposon's long terminal repeats (LTRs), similar to the packaging process used in viral vectors.
Three common transposon systems suitable for use as research tools are Sleeping Beauty, PiggyBac, and Tol2.

Transposon Mutagenesis Screens
Transposons are inherently mutagenic, making them excellent tools for mutagenesis screens to detect loss-of-function or gain-of-function mutations. In these screens, transposons encode reporter genes, mutagenic cassettes, or barcodes. When delivered to cells or model organisms, they integrate into the host genome. Next-generation sequencing is then used to detect transposon insertion sites, and analysis is performed to determine which insertions were positively or negatively selected during the experiment.
Transgenic Animals
Transgenic animals are typically generated by injecting DNA directly into the pronucleus of fertilized eggs, resulting in random integration of the sequence into the genome, a highly unpredictable process. However, transposons can efficiently integrate into the genome of fertilized eggs after injection into the cytoplasm, a process that is much less efficient when DNA is injected directly. Sleeping Beauty, piggyBac, and Tol2 have all been used to generate transgenic animals, including zebrafish, mice, rats, and rabbits.
Stable Cell Line Construction
Transposons are an alternative to lentiviral vectors for stable cell line construction, such as for iPSC reprogramming and gene and cell therapy, and they have the potential to overcome some of the limitations of viruses. Transposons (TEs) have large payloads, reaching up to 100 kB using Sleeping Beauty and piggyBac, offering a significant advantage over viral vectors (AAV payloads are approximately 5 kB, while lentiviral payloads are approximately 8 kB). Transposons are also less likely to induce an immune response than viral vectors and are easier and cheaper to produce. Both delivery methods can potentially cause gene disruption due to integration, but because TEs primarily insert into intergenic regions, gene disruption is less of a concern
sgRNA-guided Site-Specific Transposition
SgRNAs can be used to guide transposition at a specific location. The INTEGRATE system (guide RNA-assisted targeted insertion of transposable elements) has been reported to achieve approximately 100% integration of DNA fragments up to 10 kB in bacteria.
Reqbio provides stable cell line development services based on the "Transposon Integration System." To date, we have successfully generated over 300 stable cell line models, demonstrating extensive experience in electroporation-based genome integration. Please contact us to discuss your project requirements.

1、Random integration has low integration efficiency and may not necessarily integrate into the transcriptional active regions.
2、Random integration has low integration efficiency and may not necessarily integrate into the transcriptional active regions.
1、Random integration has low integration efficiency and may not necessarily integrate into the transcriptional active regions.
2、Random integration has low integration efficiency and may not necessarily integrate into the transcriptional active regions.
If you are interested in ordering, please contact us.
Customer help-line
4008-750-250
sales@reqbio.com
Office address:
3rd Floor, No. 6, Lane 222, Guangdan Road, Pudong New Area, Shanghai, China
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, and HEK293 Cell Lines Officially Secured.
Explore